Evidence map›Paper›PMID 41868434›Full record

ArticleAmerican heart journal plus : cardiology research and practice2026

Implantable cardioverter-defibrillator utilization in coronary artery spasm: A case series of cardiac arrest survivors and a patient with typical angiography.

Wen Gao, Huiyang Li, Yikai Zhao, Nanqing Xiong, Jian Li

Abstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wen GaoDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Huiyang LiDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Yikai ZhaoDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Nanqing XiongDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Jian LiDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary artery spasm (CAS) can trigger severe angina pectoris, acute coronary syndrome, or sudden cardiac arrest (SCA). Calcium channel blockers and nitrates are recommended treatments, but the role of implantable cardioverter-defibrillators (ICDs) remains controversial. This study explored ICD application in CAS via a case series of cardiac arrest survivors and a patient with typical angiography findings. Case presentation: Four patients with recurrent angina (3 with prior cardiac arrest) were diagnosed with suspected or definite CAS based on predefined criteria and coronary angiography findings: transient ST-segment elevation, nitrate-responsive coronary narrowing, and no identifiable reversible triggers. Three patients with documented ventricular tachycardia/ventricular fibrillation (VT/VF) or SCA underwent ICD implantation, while the one without such history did not. During 3.6 ± 1.3 years of follow-up, all experienced recurrent angina (reduced by maximum-tolerated calcium antagonists plus long-acting nitrates). VT/VF events in two ICD recipients were successfully terminated by anti-tachycardia pacing or shocks. Conclusions: This case series confirms recurrent angina is common in CAS and highlights the efficacy of calcium antagonists and nitrates. ICD implantation may be warranted for CAS patients who survive VT/VF, a strategy supported by the literature.

Indexed as

Case reportCoronary artery spasmImplantable cardioverter-defibrillatorsVentricular arrhythmias

Identifiers

PMID41868434
PMCPMC13000518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.